Table 6.
Clinical Outcome of non-diabetes subjects based on MAGE levels during in-hospital and 30-day follow-up
| MAGE (mmol/L) | <2.21 | 2.21-3.38 | >3.38 | P | |
|---|---|---|---|---|---|
| Subject number (n) |
164 |
55 |
55 |
54 |
NA |
| Composite MACE |
17 (10.4) |
4 (7.3) |
6 (10.9) |
7 (13) |
0.614 |
| Non-IRA revascularization | 26 (15.9) | 7 (12.7) | 9 (16.4) | 10 (18.5) | 0.704 |
Data given as mean ± SD or n (%).
MAGE, the mean amplitude of glycemic excursions; MACE, major adverse cardiac events; TVR, target vessel revascularization; IRA, infarct related arteries.